DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Host Dendritic Cells in Allograft Patients

Phase 1

Conditions: Relapsed Non-Hodgkin's Lymphoma
Hodgkin's Disease
Multiple Myeloma
Chronic Lymphocytic Lymphoma

Interventions: Biological: MSSM/BIIR HDC Vax-001 (Host Dendritic Cells)

First Posted Date: 2009-07-09

Last Posted Date: 2010-10-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT00935597

Locations: 🇺🇸
Mount Sinai Medical Center, New York, New York, United States

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Phase 2

Terminated

Conditions: Heart Failure

Interventions: Drug: Cryoprotective media alone
Biological: Mesenchymal Precursor cells (RevascorTM)

First Posted Date: 2009-06-25

Last Posted Date: 2019-03-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 10

Registration Number: NCT00927784

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Sharp Memorial Hospital, San Diego, California, United States

and more 14 locations

Evaluation of the Mobile Acute Care of the Elderly (MACE) Unit

Completed

Conditions: Model of Care for Hospitalized Older Adults

First Posted Date: 2009-06-24

Last Posted Date: 2013-08-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 346

Registration Number: NCT00927160

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6

Completed

Conditions: Breast Cancer

Interventions: Drug: Tamoxifen

First Posted Date: 2009-05-13

Last Posted Date: 2017-08-25

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 121

Registration Number: NCT00900744

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Training Community Members to Deliver HIV Prevention Programs to Urban Youth

Phase 3

Completed

Conditions: HIV
HIV Infections

Interventions: Behavioral: Reducing the Risk
Behavioral: Becoming A Responsible Teen (BART)
Behavioral: Be Proud! Be Responsible!

First Posted Date: 2009-03-10

Last Posted Date: 2012-03-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 901

Registration Number: NCT00859144

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type

Not Applicable

Completed

Conditions: ADHD

Interventions: Drug: Placebo
Drug: methylphenidate

First Posted Date: 2009-01-16

Last Posted Date: 2009-01-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT00824317

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

Not Applicable

Completed

Conditions: Liver Cirrhosis
Coagulopathy

Interventions: Drug: Desmopressin
Biological: blood transfusion

First Posted Date: 2008-12-31

Last Posted Date: 2009-01-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 36

Registration Number: NCT00816127

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Parent-Based Treatment for Pediatric Overweight

Phase 1

Completed

Conditions: Overweight
Obesity

Interventions: Behavioral: FBT-PO
Behavioral: NEC

First Posted Date: 2008-12-12

Last Posted Date: 2016-01-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 77

Registration Number: NCT00807560

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, NY, New York, United States

Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation

Phase 2

Completed

Conditions: Mitral Valve Insufficiency
Coronary Artery Disease

Interventions: Procedure: Mitral Valve Replacement
Procedure: Mitral Valve Repair with Annuloplasty

First Posted Date: 2008-12-11

Last Posted Date: 2019-03-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 251

Registration Number: NCT00807040

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States
🇺🇸
Montefiore Einstein Heart Center, Bronx, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

and more 18 locations

Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation

Not Applicable

Completed

Conditions: Coronary Artery Disease
Mitral Valve Insufficiency

Interventions: Procedure: Mitral Valve Repair
Procedure: CABG

First Posted Date: 2008-12-11

Last Posted Date: 2017-06-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 301

Registration Number: NCT00806988

Locations: 🇺🇸
Washington University, St Louis, Missouri, United States
🇺🇸
Baystate Medical Center, Springfield, Massachusetts, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

and more 24 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy